Adrenal Insufficiency Revealing a Bilateral Adrenal Hemorrhage-Adrenal Infarction Related to Antiphospholipid Syndrome

Published:September 08, 2021DOI:
      In June 2020, a 54-year-old female presented with severe fatigue that had been worsening over the past few weeks. She had a history of primary triple positive (lupus anticoagulant, anticardiolipin and anti-β2GP1 antibodies) antiphospholipid syndrome (APS) revealed 19 years ago by a venous thromboembolism, and had been long-term treated with warfarin.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Cervera R
        • Piette JC
        • Font J
        • et al.
        Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1,000 patients.
        Arthritis Rheum. 2002; 46: 1019‑1027
        • You JY
        • Fleischer N
        • Abraham SB
        Evolving adrenal dysfunction after bilateral adrenal infarction: a case report.
        AACE Clin Case Rep. 2019; 5: e334-e339
        • Espinosa G
        • Santos E
        • Cervera R
        • et al.
        Adrenal involvement in the antiphospholipid syndrome: clinical and immunologic characteristics of 86 patients.
        Medicine (Baltimore). 2003; 82: 106‑118
        • Ramon I
        • Mathian A
        • Bachelot A
        • et al.
        Primary adrenal insufficiency due to bilateral adrenal hemorrhage-adrenal infarction in the antiphospholipid syndrome: long-term outcome of 16 patients.
        J Clin Endocrinol Metab. 2013; 98: 3179‑3189